| http://dbpedia.org/ontology/abstract
|
Molecular Partners AG is a clinical-stage … Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.e of molecules in preclinical development.
|
| http://dbpedia.org/ontology/assets
|
1.456E8
|
| http://dbpedia.org/ontology/foundingYear
|
2004
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Chief_Medical_Officer +
, http://dbpedia.org/resource/Chairman_of_the_Board +
, http://dbpedia.org/resource/Chief_Operating_Officer +
, http://dbpedia.org/resource/Chief_Financial_Officer +
|
| http://dbpedia.org/ontology/locationCity
|
http://dbpedia.org/resource/Canton_of_Z%C3%BCrich +
, http://dbpedia.org/resource/Schlieren%2C_Switzerland +
, http://dbpedia.org/resource/Switzerland +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
152
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Molecular_Partners_Logo.jpg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.molecularpartners.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
48536390
|
| http://dbpedia.org/ontology/wikiPageLength
|
8739
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1113856398
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Swiss_companies_established_in_2004 +
, http://dbpedia.org/resource/Novartis +
, http://dbpedia.org/resource/Genetically-engineered +
, http://dbpedia.org/resource/Switzerland +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Protein +
, http://dbpedia.org/resource/Diagnosis +
, http://dbpedia.org/resource/Chairman_of_the_Board +
, http://dbpedia.org/resource/Ankyrin_repeat +
, http://dbpedia.org/resource/Immuno-oncology +
, http://dbpedia.org/resource/SIX_Swiss_Exchange +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_SIX_Swiss_Exchange +
, http://dbpedia.org/resource/Antibody_mimetic +
, http://dbpedia.org/resource/Kilodaltons +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Chief_Medical_Officer +
, http://dbpedia.org/resource/COVID-19 +
, http://dbpedia.org/resource/Swiss_franc +
, http://dbpedia.org/resource/Pre-clinical_development +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Switzerland +
, http://dbpedia.org/resource/Category:Companies_based_in_Z%C3%BCrich +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2004 +
, http://dbpedia.org/resource/Chief_Financial_Officer +
, http://dbpedia.org/resource/Therapeutic +
, http://dbpedia.org/resource/Molecular_mass +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2004 +
, http://dbpedia.org/resource/University_of_Z%C3%BCrich +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Switzerland +
, http://dbpedia.org/resource/Z%C3%BCrich%2C_Switzerland +
, http://dbpedia.org/resource/Category:2021_initial_public_offerings +
, http://dbpedia.org/resource/Ophthalmology +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Chief_Operating_Officer +
, http://dbpedia.org/resource/DARPin +
, http://dbpedia.org/resource/Allergan +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Public +
, http://dbpedia.org/resource/Schlieren%2C_Switzerland +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Canton_of_Z%C3%BCrich +
|
| http://dbpedia.org/property/assets
|
1.456E8
|
| http://dbpedia.org/property/founded
|
2004
|
| http://dbpedia.org/property/homepage
|
http://www.molecularpartners.com/ +
|
| http://dbpedia.org/property/hqLocationCity
|
Schlieren, Zürich, Switzerland
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
William M. Burns, Chairman of the Board
, Dr. Patrick Amstutz, Chief Executive Officer
, Dr. Nicolas Leupin, Chief Medical Officer
, Andreas Emmenegger, Chief Financial Officer
, Dr. Michael Stumpp, Chief Operating Officer
|
| http://dbpedia.org/property/logo
|
Molecular_Partners_Logo.jpg
|
| http://dbpedia.org/property/name
|
Molecular Partners AG
|
| http://dbpedia.org/property/numEmployees
|
152
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:MOLN
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:SWX +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2004 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Switzerland +
, http://dbpedia.org/resource/Category:Swiss_companies_established_in_2004 +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2004 +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_SIX_Swiss_Exchange +
, http://dbpedia.org/resource/Category:2021_initial_public_offerings +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Switzerland +
, http://dbpedia.org/resource/Category:Companies_based_in_Z%C3%BCrich +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Molecular_Partners?oldid=1113856398&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Molecular_Partners_Logo.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.molecularpartners.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Molecular_Partners +
|
| http://xmlns.com/foaf/0.1/name
|
Molecular Partners AG
|
| owl:sameAs |
http://yago-knowledge.org/resource/Molecular_Partners +
, https://global.dbpedia.org/id/2MqEc +
, http://dbpedia.org/resource/Molecular_Partners +
, http://www.wikidata.org/entity/Q25111777 +
|
| rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
|
| rdfs:comment |
Molecular Partners AG is a clinical-stage … Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.e of molecules in preclinical development.
|
| rdfs:label |
Molecular Partners
|
